American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics . 2000;105(5):1158-1170.
American Psychiatric Association. Attention deficit/hyperactivity disorder. In: Diagnostic and Statistical Manual of Mental Disorders . 4th ed. Washington, DC: American Psychiatric Association; 1994:78-85.
Arnold LE, Pinkham SM, Votolato N. Does zinc moderate essential fatty acid and amphetamine treatment of attention deficit/hyperactivity disorder? J Child Adolesc Psychopharmacol . 2000;10:111-117.
Arnold LE, Kleykamp D, Votolato N, Gibson RA, Horrocks L. Potential link between dietary intake of fatty acid and behavior: pilot exploration of serum lipids in attention-deficit hyperactivity disorder . J Child Adolesc Psychopharmacol . 1994;4(3):171-182.
Baumgaertel A. Alternative and controversial treatments for attention-deficit/hyperactivity disorder. Pediatr Clin of North Am . 1999;46(5):977-992.
Bekaroglu M, Aslan Y, Gedik Y. Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: a research note. J Child Psychol Psychiatry . 1996;37(2):225-227.
Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, Mass: Integrative Medicine Communications; 1998:160, 107.
Boris M, Mandel F. Foods and additives are common causes of the attention deficit hyperactive disorder in children. Ann Allergy.1994;72:462-468.
Breakey J. The role of diet and behaviour in childhood. J Paediatr Child Health. 1997; 33:190-194.
Burgess J, Stevens L, Zhang W, Peck L. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr. 2000; 71(suppl):327S-330S.
Carter CM, Urbanowicz M, Hemsley R, et al. Effects of a few food diet in attention deficit disorder. Arch Dis Child . 1993;69:564-568.
Daruna JH, Dalton R, Forman MA. Attention deficit hyperactivity disorder. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 16 th ed. Philadelphia, Pa: W.B. Saunders Company; 2000:100-103.
Daviss WB, Bentivoglio P, Racusin R, et al. Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. J Am Acad Child Adolesc Psychiatry . 2001;40(3):307-314.
Escher M, Desmeules J, Giastra E, Mentha G. Hepatitis associated with kava, a herbal remedy for anxiety. BMJ . 2001;322:139.
Field T, Quintino O, Hernandez-Reif M, Koslovsky G. Adolescents with attention deficit hyperactivity disorder benefit from massage therapy. Adolescence . 1998;33(129):103-108.
Food and Drug Administration. Medwatch: the FDA safety information and adverse event reporting program. Cylert (pemoline). Accessed athttp://www.fda.gov/medwatch/safety/1999/cylert19.htm on November 16, 2001.
Gutgesell H, Atkins D, Barst R, et al. Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: a statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 1999; 99(7):979-82.
Gruenwald J, Brendler T, Jaenicke C, et al., eds. PDR for Herbal Medicines. Montvale, NJ: Medical Economics Co; 1998:929, 961-963, 967-968, 991-992, 1015-1016.
Jan JE, Espezel H, Freeman RD, Fast DK. Melatonin treatment of chronic sleep disorders . J Child Neurol. 1998; 13(2):98.
Kanarek R. Does sucrose or aspartame cause hyperactivity in children? Nutr Rev.1994;52(5):173-175.
Kidd P. Attention deficit / hyperactivity disorder (ADHD) in children: rationale for its integrative management. Altern Med Rev.2000;5(5):402-428.
Knochel JP. Disorders of magnesium metabolism. In: Fauci AS, Braunwald E, Isselbacher KJ, eds. Harrison’s Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill Companies, Inc; 1998:2263.
Kozielec T, Starobrat-Hermelin B. Assessment of magnesium levels in children with attention deficit hyperactivity disorder. Magnes Res . 1997;10(2):143-148.
Krummel D, Seligson FH, Guthrie HA. Hyperactivity: is candy causal? Critical Reviews in Food Science and Nutrition . 1996;36(1 and 2):31-47.
Lamont J. Homoeopathic treatment of attention deficit hyperactivity disorder; a controlled study. Br Homoeopath J. 1997;86:196-200.
Lee S. Biofeedback as a treatment for childhood hyperactivity: a critical review of the literature.Psychol Rep . 1991;68:163-192.
Linden M, Habib T, Rodojevic V. A controlled study of the effects of EEG biofeedback on cognition and behavior of children with attention deficit disorder and learning disabilities.Biofeedback Self Regul . 1996;21(1):35-49.
Lubar J, Swartwood MO, Swartwood JN, O’Donnell PH. Evaluation of the effectiveness of EEG neurofeedback training for ADHD in a clinical setting as measured by changes in TOVA scores, behavioral ratings and WISC-R performance. Biofeedback Self Regul . 1995;20(1):83-99.
Lyon MR, Cline JC, Totosy de Zepetnek J, et al. Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study. J Psychiatry Neurosci. 2001;26(3):221-228.
Mitchell EA, Aman MG, Turbott SH, Manku M. Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clin Pediatr (Phila). 1987;26:406-411.
Morrison R. Desktop Guide to Keynotes and Confirmatory Symptoms. Albany, Calif: Hahnemann Clinic Publishing; 1993:33-36, 39-44, 115-117.
MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1073-1086.
National Institute of Mental Health. Attention deficit hyperactivity disorder. Accessed at:http://www.nimh.nih.gov/publicat/adhd.cfm on November 9, 2001.
National Institutes of Health. Diagnosis and treatment of attention deficit hyperactivity disorder: National Institutes of Health Consensus Development Conference Statement. November 16-18, 1998. Accessed at: http://odp.od.nih.gov/consensus/cons/110/110_statement.htm on November 9, 2001.
Richardson AJ, Puri BK. The potential role of fatty acids in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids . 2000;63(1/2):79-87.
Rowe KS, Rowe KJ. Synthetic food coloring and behavior: a dose response effect in a double-blind, placebo-controlled, repeated measures study. J Pediatr . 1994;125:691-698.
Sever Y, Ashkenazi A, Tyano S, Weizman A. Iron Treatment in children with attention deficit Hyperactivity disorder: a preliminary report. Neuropsychobiology . 1997; 35:178-180.
Starobrat-Hermelin B, Kozielec T. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactive disorder (ADHD): positive response to magnesium oral loading test. Magnesium Research . 1997; 10(2):149-156.
Stevens LJ, Zentall SS, Abate ML, Kuczek T, Burgess JR. Omega-3 fatty acids in boys with behavior, learning and health problems. Physiol Behav . 1996;59(4/5):915-920.
Stevens LJ, Zentall SS, Deck JL, et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr. 1995;62:761-768.
Stubberfield TG, Wray JA, Parry TS. Utilization of alternative therapies in attention-deficit hyperactivity disorder. J Paediatr Child Health . 1999;35:450-453.
Tan G, Schneider S. Attention-deficit hyperactivity disorder: pharmacotherapy and beyond.Postgrad Med . 1997;101(5):201-222.
Thompson L, Thompson M. Neurofeedback combined with training in metacognitive strategies: effectiveness in students with ADD. Appl Psychophysiol Biofeedback . 1998;23(4):243-263.
Toren P, Eldar S, Sela BA, et al. Zinc deficiency in attention-deficit hyperactivity disorder. Biol Psychiatry . 1996; 40:1308-1310.
Volkow ND, Wang G, Fowler JS, et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci. 2001;15;21(2):RC121.
Wender EH. The food additive-free diet in the treatment of behavior disorders: a review. J Dev Behav Pediatr. 1986;7(1):35-42.
Wender PH, Wolf LE, Wasserstein J. Adults with ADHD. An overview. Ann N Y Acad Sci . 2001;931:1-16.
Werbach M. Nutritional Influences on Illness. New Canaan, Conn: Keats Publishing; 1988:221-226.
Wolraich M, Lindgren SD, Stumbo PJ, et al. Effects of diets in sucrose or aspartame on the behavior and cognitive performance of children. N Engl J Med. 1994;330:301-307.
Wolraich M. Addressing behavior problems among school-aged children: traditional and controversial approaches. Pediatr Rev . 1997;18(8):266-270.
Wolraich M, Baumgaertel A. The practical aspects of diagnosing and managing children with attention deficit hyperactivity disorder. Clin Pediatr (Phila) . 1997;36(9):497-504.